Vaccination alone cannot eliminate cervical cancer. In the light of WHO's 90-70-90 strategy, discuss what India must do in screening and treatment.
New · District CollectorCan you hold the district for 72 hours?Floods, a heatwave, an outbreak, a grievance queue. Take the decisions, see the consequences.Play →In this answer
WHO's Global Strategy (2020) sets three 90-70-90 targets for 2030. The first is 90% of girls vaccinated by age 15. The second is 70% of women screened with a high-performance test by 35 and again by 45. The third is 90% of women with cervical disease treated [1]. India's single-dose campaign has covered nearly 87% of its cohort of 14-year-old girls [2]. That secures only the first of these three pillars.
Why vaccination alone falls short
- Time lag: girls vaccinated at 14 reach the high-risk ages only decades later. Women who are already adults can be protected only through screening and treatment [1].
- Girls already past 14: the campaign covers only one age group, so girls older than 14 at launch stay unprotected [2].
Screening: closing the "70" gap
- Low coverage: WHO's country profile found that fewer than 1 in 10 Indian women had been screened in the previous five years [3]. The National NCD Portal records 10.18 crore of 25.42 crore eligible women screened, about 40% [4].
- Test quality: India relies mainly on VIA (visual inspection with acetic acid) [4]. WHO's target counts only high-performance tests [1]. Current methods are costly and only moderately sensitive [5].
- Way forward:
- roll out validated indigenous point-of-care HPV DNA tests at Ayushman Arogya Mandirs [6][5];
- link U-WIN vaccination records with the NCD Portal, so that vaccinated girls are automatically called for screening at 30 [2][4];
- use ASHAs and ANMs, who built trust in the vaccination drive, to overcome stigma and bring women in for tests [2].
Treatment: delivering the second "90"
- Screen-and-treat: treat precancerous lesions at the same visit, so that women who test positive are not lost to follow-up.
- Referral chain: from Ayushman Arogya Mandirs to district hospitals to tertiary cancer centres, with each case tracked on the NCD Portal [4].
- Capacity: train Medical Officers and nurses to treat precancerous lesions, and expand pathology, surgery and palliative care at district level.
- Financial protection: make sure treatment is affordable so that families are not forced into ruinous health spending.
Vaccination protects the next generation. Screening and treatment protect the women who are at risk today. India should run the three pillars as one continuous system: vaccinate, test with HPV DNA, and treat promptly. That would turn the 1-crore-dose milestone into real progress on elimination and on SDG 3.4, which aims to cut early deaths from non-communicable diseases by one-third.
Sources
- 1WHO: Global strategy to accelerate the elimination of cervical cancer as a public health problem (2020)the 90-70-90 targets; high-performance test standard
- 2PIB: India crosses 1 crore HPV vaccine dosesabout 87% cohort coverage; vaccination limited to 14-year-olds; U-WIN; ASHAs and ANMs
- 3WHO: Cervical cancer country profiles (India, 2021)fewer than 1 in 10 women screened in the previous five years
- 4PIB: 10.18 Crore Women Screened for Cervical Cancer Under Ayushman Arogya Mandirs and NHMNational NCD Portal screening count; VIA-based screening
- 5PIB: Dr. Jitendra Singh reviews indigenously developed HPV test kits for cervical cancer screeningcurrent methods costly and only moderately sensitive; indigenous HPV test kits
- 6PIB: Ministry of Health & Family Welfare Initiatives & Achievements 2025validated indigenous point-of-care HPV DNA test